Gui-zhi-fu-ling-wan alleviates bleomycin-induced pulmonary fibrosis through inhibiting epithelial-mesenchymal transition and ferroptosis

Authors: Zi-Yong Chen, Meng-Meng Ma, Rui Wang, Qing-Qing Zhang, Mei-Ling Xie, Ying-Li Wang, Yong-Xia Guo, Kui Liu, Li-Fang Cao, Feng-Lian He, Lin Fu, Ya-Lin Jiang

Source: Frontiers in Pharmacology, Vol 16 (2025)

Subject Terms: gui-zhi-fu-ling-wan, pulmonary fibrosis, bleomycin, epithelial-mesenchymal transition, ferroptosis, mitochondrial reactive oxygen species, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2025.1552251/full; https://doaj.org/toc/1663-9812

Access URL: https://doaj.org/article/d631e57e62fe43c4a957ecd0bf174f7f